{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:19:23Z","timestamp":1767971963524,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.urolonc.2022.09.006","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T10:05:24Z","timestamp":1665396324000},"page":"540.e11-540.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Heterogeneity in the pharmacological management of radiation-induced hemorrhagic cystitis"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7810-4104","authenticated-orcid":false,"given":"Brendan K.","family":"Wallace","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton M.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George W.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Smigelski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7062-5001","authenticated-orcid":false,"given":"Christopher B.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2022.09.006_bib0001","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/cncr.32570","article-title":"Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends","volume":"126","author":"Tang","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0002","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrurol.2010.23","article-title":"Management of radiation cystitis","volume":"7","author":"Smit","year":"2010","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0003","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003455","article-title":"Group N and OC. Non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis","author":"Denton","year":"2002","journal-title":"Cochrane Database Syst Rev 2002"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0004","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4240\/wjgs.v8.i7.483","article-title":"Chronic haemorrhagic radiation proctitis: A review","volume":"8","author":"Ramakrishnaiah","year":"2016","journal-title":"World J Gastrointest Surg"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0005","first-page":"57","article-title":"Challenges and Opportunities in Radiation-induced Hemorrhagic Cystitis","volume":"18","author":"Zwaans","year":"2016","journal-title":"Rev Urol"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0006","first-page":"1","article-title":"Development of a Management Algorithm for Acute and Chronic Radiation Urethritis and Cystitis","author":"Vanneste","year":"2021","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0007","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.urology.2019.05.034","article-title":"Incidence and Morbidity of Radiation-Induced Hemorrhagic Cystitis in Prostate Cancer","volume":"131","author":"Martin","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0008","first-page":"15","article-title":"Canadian Urological Association Best Practice Report: Diagnosis and management of radiation-induced hemorrhagic cystitis","volume":"13","author":"Goucher","year":"2019","journal-title":"Can Urol Assoc J"},{"issue":"75","key":"10.1016\/j.urolonc.2022.09.006_bib0009","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s40265-015-0443-5","article-title":"A Practical Approach to the Management of Radiation-Induced Hemorrhagic Cystitis","author":"Liem","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0010","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/SPC.0000000000000375","article-title":"A contemporary review about the management of radiation-induced hemorrhagic cystitis","volume":"12","author":"Dautruche","year":"2018","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0011","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/bju.14516","article-title":"Current management of radiation cystitis: a review and practical guide to clinical management","volume":"123","author":"Pascoe","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0012","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.5489\/cuaj.4047","article-title":"Intravesical formalin for hemorrhagic cystitis: A contemporary cohort","volume":"11","author":"Ziegelmann","year":"2017","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0013","first-page":"66","article-title":"Alum irrigation for the treatment of intractable haematuria","volume":"16","author":"Ho","year":"2009","journal-title":"Malays J Med Sci"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0014","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1590\/s1677-5538.ibju.2015.0588","article-title":"Safety and efficacy of intravesical alum for intractable hemorrhagic cystitis: A contemporary evaluation","volume":"42","author":"Westerman","year":"2016","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0015","first-page":"7","article-title":"A comparative study of intravesical instillation of 15(s) 15 Me alpha and alum in the management of persistent hematuria of vesical origin","volume":"30","author":"Praveen","year":"1992","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0016","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0090-4295(92)90479-G","article-title":"Intravesical epsilon aminocaproic acid in management of intractable bladder hemorrhage","volume":"40","author":"Singh","year":"1992","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0017","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0090-4295(01)01586-2","article-title":"Effect of pentosan polysulfate therapy on intravesical potassium sensitivity","volume":"59","author":"Parsons","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0018","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1464-410X.2004.05044.x","article-title":"The management of haemorrhagic cystitis with sodium pentosan polysulphate","volume":"94","author":"Sandhu","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0019","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000475245","article-title":"Sodium pentosanpolysulphate in the management of haemorrhagic cystitis: experience with 14 patients","volume":"25","author":"Hampson","year":"1994","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0020","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0022-5347(17)41016-0","article-title":"Intravesical formalin for hemorrhagic cystitis: Analysis of therapy","volume":"141","author":"Donahue","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0021","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1046\/j.1464-410x.2000.00900.x","article-title":"The management of intractable haematuria","volume":"86","author":"Choong","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0022","first-page":"15","article-title":"Canadian Urological Association Best Practice Report: Diagnosis and management of radiation-induced hemorrhagnotepadic cystitis","volume":"13","author":"Goucher","year":"2019","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0023","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2146\/news080007","article-title":"USP releases revision of chapter on sterile compoundingNew version of USP chapter 797 emphasizes personnel","volume":"65","author":"Thompson","year":"2008","journal-title":"Am J Heal Pharm"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0024","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2146\/ajhp050447","article-title":"Impact of United States Pharmacopeia chapter 797: results of a national survey","volume":"63","author":"Candy","year":"2006","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0025","first-page":"8","article-title":"Solving Compounding Challenges in Hemorrhagic Cystitis Management","volume":"18","author":"Wright","year":"2021","journal-title":"Pharm Purch Prod"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0026","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.prnil.2020.07.006","article-title":"Radiation-induced haemorrhagic cystitis after prostate cancer radiotherapy: factors associated to hospitalization and treatment strategies","volume":"9","author":"Sanguedolce","year":"2021","journal-title":"Prostate Int"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0027","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0140-6736(93)92244-N","article-title":"Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations","volume":"342","author":"Grimshaw","year":"1993","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0028","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/bmj.318.7182.527","article-title":"Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines","volume":"318","author":"Woolf","year":"1999","journal-title":"BMJ Br Med J"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0029","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.pu.14.050193.001251","article-title":"Containing costs while improving quality of care: The role of profiling and practice guidelines","volume":"14","author":"Shapiro","year":"1993","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.urolonc.2022.09.006_bib0030","doi-asserted-by":"crossref","DOI":"10.1007\/s11934-018-0790-3","article-title":"Scoping review and meta-analysis of hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis","volume":"19","author":"Cardinal","year":"2018","journal-title":"Curr Urol Rep"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922003143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922003143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:26:13Z","timestamp":1761042373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143922003143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1078143922003143"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.09.006","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneity in the pharmacological management of radiation-induced hemorrhagic cystitis","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}